News and Announcements
Shivom: Kickstarting 2019 with a splendid vision
- Published January 08, 2019 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
KEY TAKEAWAYS:
- 2018 was a successful year for Shivom as they launched the Alpha version of their product.
- The company featured on CNBC Advancements’.
- Henry Ines, Shivom’s CEO, appeared on NASDAQ’s Innovators segment hosted by Jane King.
2018 was a successful year for Shivom as they launched the Alpha version of their product and actively engaged in several key partnerships. At the end of 2018, Shivom featured in CNBC Advanvements’ segment, hosted by Ted Danson. Advancements is an educational series dedicated to informing the public about the latest innovations taking place today. Advancements explores the significant issues impacting society and aim to uncover the best kept secrets to raise social awareness. The segment focused on new technologies such as blockchain, cryptocurrency and AI. Shivom was pleased to feature on the segment alongside other startups such as Bethereum, Paytomat and ETouchMenu. This year, Shivom’s CEO appeared on NASDAQ’s innovators hosted by Jane King. He discussed the future of precision medicine and product updates.
Recently, Shivom has been widely featured across CNBC, CNBC Africa, Kron 4 (San Francisco Bay Area), Fox Business News and Bloomberg. A 12-part interview series with Nasdaq will also widespread their mission globally.
Upcoming Events for Shivom
- Blockchain Connect Conference @ San Francisco Marriott Marquis – January 11
- Precision Medicine World Conference 2018 @ Santa Clara Convention Center, Silicon Valley, USA – January 21 – 23
- Blockchain Applications for Pharma @ Hyperion Hotel, Basel, Switzerland – January 23 – 24
About Shivom
Shivom combines blockchain, A.I., DNA sequencing & cryptography to enable secure and personalized medicine. The Shivom platform works on collaboration & integrity, allowing people to own, manage and monetize their data. By creating a web-marketplace, a network of genomic counsellors, and a not-for-profit drug research unit, Shivom will build a global healthcare ecosystem, reaching even low-income countries.
Company Updates
The Index Approach in Early-Stage Venture Capital: Reconsidered
The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]
The Future Is Now: The Evolution of Dealflow with Wholesale Investor
If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]
Investability of a Startup: A Comprehensive Guide for Angels and High-Net Worth Investors
Venturing into the Startup Scene Let’s dive into the intriguing world of startups. It’s a thrilling ride, isn’t it? Like finding a pearl in an ocean, spotting a promising startup amidst a sea of businesses is no easy task. This guide aims to light the way, focusing on the “The Investability of a Startup: 7 […]
Backed By Leading Investment Groups and Family Offices
